Description
The purpose of this Notice of Intent to Amend is to notify that, as a result of consultation, Health Canada will switch certain uses of Esomeprazole to nonprescription status for human use by modifying the Human Prescription Drug List (PDL).
Resources
| Name | Format | Description | Link |
|---|---|---|---|
| Notice - Prescription Drug List (PDL): Esomeprazole | HTML | Open resource | |
| Notice - Prescription Drug List (PDL): Esomeprazole | HTML | Open resource |